Evidence map›Paper›PMID 26550113›Full record

ArticleInternational journal of clinical and experimental medicine2015

IL-6/STAT3/SOCS3 signaling pathway playing a regulatory role in ulcerative colitis carcinogenesis.

Ying-Ying Chen, Zhi-Bin Ma, Hong-Yu Xu, Li-Jun Shi, Dong-Yue Li, Li-Ying Sun, Xun-Hai Yin, Guo-Yin Sang, Dan Xu, Yin-Hua Tang and 4 more

Abstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in pharmacology · 2020
    Article
  8. Article
  9. Article
  10. Polysaccharide extracted fromAmerican journal of translational research · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Ying-Ying ChenDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Zhi-Bin MaDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Hong-Yu XuDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Li-Jun ShiDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Dong-Yue LiDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Li-Ying SunDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Xun-Hai YinDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Guo-Yin SangDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Dan XuDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Yin-Hua TangDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Xi WangDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Peng LiDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Feng WuDepartment of Gastroenterology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Jin ZhouDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University Harbin 150001, Heilongjiang Province, P. R. China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLarge-scale clinical studies have shown that ulcerative colities were related with colorectal cancer. In this study, animal model was established by AOM/DSS method to explore the activation of IL-6-STAT3-SOCS3 signaling pathway and the expression of pathway-related proteins in ulcerative colitis carcinogenesis, in order to lay a foundation for exploring the regulation mechanism of IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis carcinogenesis.

methodAOM/DSS modeling method was used to establish animal models of ulcerative colitis carcinogenesis; colonic mucosa specimens were collected at different time points for pathological examination. Immunohistochemical method and western blot were used to detect the expression of IL6, STAT3 and SOCS3 protein in the control group, UC model + empty vector group and UC model + STAT3 knockout group.

resultsIn UC model + empty vector group, IL6 and STAT3 expression was increased as lesion degree increased (P < 0.05). The expression of SOCS3 was weakened and the degree of activation decreased (P < 0.05). IL6 expression increased in UC model + STAT3 knockout group (P < 0.05) while the expression of SOCS3 decreased; compared with the UC model + empty vector group, there was a significant difference (P < 0.05).

conclusionThe expression and activation of IL6 and STAT3 expression were enhanced in ulcerative colitis carcinogenesis, and their expression increased with the lesion degree increased, reflecting the disease progression to a certain extent. The expression and activation of SOCS3 expression decreased. STAT3 had a certain effect on the expression of SOCS3, playing a certain regulatory role in ulcerative colitis carcinogenesis.

Indexed as

IL-6signaling pathwaysSOCS3STAT3Ulcerative colitis

Identifiers

PMID26550113
PMCPMC4612798
OpenAlexW2192127972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.